SCHEMBL16852182

SCHEMBL16852182

CCOc1nc(N)nc(OCN)c1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ MAPK1 P28482 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CDK1 P06493 8/20 0.33
▸ CCNB1 P14635 8/20 0.33
▸ CCNA2 P20248 6/20 0.33
▸ CDK2 P24941 6/20 0.33
▸ CCNA1 P78396 6/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ PIN1 Q13526 1/20 0.33
▸ CA12 O43570 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ AOC3 Q16853 1/20 0.31
▸ TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16828155 0.91 SMN1; SMN2 (0.40) SMN1; SMN2LMNAMAPK1NPC1ALDH1A1
Hydrochloric Acid SCHEMBL16828217 0.89 SMN1; SMN2 (0.39) SMN1; SMN2LMNAMAPK1NPC1ALDH1A1
SCHEMBL16828215 0.89 CDK1 (0.31) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL16828244 0.84 CDK1 (0.49) LMNAMAPK1NPC1ALDH1A1RAB9A
SCHEMBL16828159 0.83 CCNA2 (0.40) SMN1; SMN2LMNAMAPK1NPC1ALDH1A1
SCHEMBL16828165 0.83 CCNA2 (0.40) ALDH1A1CDK1CCNB1CCNA2CDK2
SCHEMBL16852117 0.82 CDK1 (0.50) SMN1; SMN2LMNAMAPK1NPC1ALDH1A1
SCHEMBL16828151 0.82 SMN1; SMN2 (0.35) SMN1; SMN2LMNAMAPK1NPC1ALDH1A1
SCHEMBL4450496 0.81 CDK2 (0.37) SMN1; SMN2LMNAMAPK1NPC1ALDH1A1
SCHEMBL18134207 0.79 MAPK1 (0.41) SMN1; SMN2LMNAMAPK1NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9636288-B2 Means for oxidative dyeing of keratin fibers containing novel tetra-substituted derivatives of pyrimidine HENKEL AG & CO. KGAA (DE) 2017-05-02 — — US disclosed
US-9636288-B2 Means for oxidative dyeing of keratin fibers containing novel tetra-substituted derivatives of pyrimidine HENKEL AG & CO. KGAA (DE) 2017-05-02 — — US disclosed
US-9636288-B2 Means for oxidative dyeing of keratin fibers containing novel tetra-substituted derivatives of pyrimidine HENKEL AG & CO. KGAA (DE) 2017-05-02 — — US disclosed
US-20160296447-A1 MEANS FOR OXIDATIVE DYEING OF KERATIN FIBERS CONTAINING NOVEL TETRA-SUBSTITUTED DERIVATIVES OF PYRIMIDINE HENKEL AG & CO. KGAA (DE) 2016-10-13 — — US disclosed
US-20160296447-A1 MEANS FOR OXIDATIVE DYEING OF KERATIN FIBERS CONTAINING NOVEL TETRA-SUBSTITUTED DERIVATIVES OF PYRIMIDINE HENKEL AG & CO. KGAA (DE) 2016-10-13 — — US disclosed
US-20160296447-A1 MEANS FOR OXIDATIVE DYEING OF KERATIN FIBERS CONTAINING NOVEL TETRA-SUBSTITUTED DERIVATIVES OF PYRIMIDINE HENKEL AG & CO. KGAA (DE) 2016-10-13 — — US disclosed
WO-2015090292-A1 MEANS FOR OXIDATIVE DYEING OF KERATIN FIBERS CONTAINING NOVEL TETRA-SUBSTITUTED DERIVATIVES OF PYRIMIDINE HENKEL AG & CO. KGAA (DE) 2015-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160296447-A1 MEANS FOR OXIDATIVE DYEING OF KERATIN FIBERS CONTAINING NOVEL TETRA-SUBSTITUTED DERIVATIVES OF PYRIMIDINE KRT18, TK1, DPYD SMN1; SMN2 4219/4885LMNA 1885/4885MAPK1 1107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback